Clinical Trials Directory

Trials / Completed

CompletedNCT04582708

Use of NERv's Inline Device as an Early Diagnostic Method for Postoperative Complications

Use of NERv's Inline Device for the Continuous Monitoring of pH and Conductivity as an Early Diagnostic Method for Postoperative Complications

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
316 (actual)
Sponsor
FluidAI Medical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

NERv's traditional feasibility clinical trial is a multi-center, pre-market, single-arm, and non-randomized trial. This study will involve the retrospective analysis of prospectively collected data. The trial is intended to establish the safety of NERv's Inline Device and collect preliminary data to illustrate the change in pH and electrical conductivity during normal postoperative recovery and in the event of a complication. The purpose of NERv's feasibility study is to establish a clinical model that shows the progressive change in pH and electrical conductivity during a normal post-operative recovery and in the event of an anastomotic leak in colorectal, hepatobiliary (HPB), trauma, and general surgery patients. Upon analyzing data collected from NERv's Inline Device, a clinical model of change in pH and conductivity over time will be created. The clinical model can be used in future stages to determine if a complication is developing. For instance, boundaries (reading thresholds) can be established to detect a complication when readings exceed such boundaries.

Conditions

Interventions

TypeNameDescription
DEVICENERv's Inline DeviceNERv's Inline Device is comprised of multiple sensors. It attaches in line to existing catheters or peritoneal drains that are currently approved for medical use. This allows the device to measure the pH and electrical conductivity of effluent fluids that are drained through peritoneal drains.

Timeline

Start date
2020-11-09
Primary completion
2024-09-24
Completion
2024-09-24
First posted
2020-10-09
Last updated
2025-10-10

Locations

7 sites across 3 countries: United States, Canada, Saudi Arabia

Source: ClinicalTrials.gov record NCT04582708. Inclusion in this directory is not an endorsement.